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A B S T R A C T
Background
Previous reports have shown that ion content in the air may have an effect on respiratory function. Results from studies which test the
efficacy of air ionisers to reduce asthma symptoms are often inconclusive and their use as a treatment for asthma remains debatable.
Objectives
We conducted a systematic review of the available evidence to determine the effectiveness of positive and negative ion generators in
people with asthma.
Search methods
We searched the Cochrane Airways Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL) as well
as the alternative medicine database AMED. Searches were current as of January 2010.
Selection criteria
Randomised controlled trials (parallel or crossover design studies) comparing ionisers with dummy ionisers (being negative or positive
ion emitters), in children or adults with chronic asthma.
Data collection and analysis
Two reviewers independently assessed titles and abstracts of studies and assessed trial quality. Study quality was determined using two
methods:The Cochrane approach to allocation concealment and the five point Jadad scale.
Main results
Six studies were selected for inclusion (106 participants). No results were combined as the studies were all of a crossover design.
EFFECTS OF NEGATIVE ION GENERATORS (five studies)
No study reported a significant difference in lung function between ionised and control air (morning Peak expiratory flow (PEF) -
three studies; forced expiratory flow in one second (FEV1) - one study). There were no significant differences in symptoms or beta-2
agonist usage between ionised and control air in three studies.
EFFECTS OF POSITIVE ION GENERATORS (one study)
This study demonstrated that although positively ionised air was associated with a larger fall in FEV1 with exercise, this did not reach
statistical significance. Baseline FEV1 was not demonstrated to be significantly different between treatment groups.
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Authors’ conclusions
Based on the evidence currently available from randomised controlled trials, a recommendation cannot be given for the use of room
air ionisers to reduce symptoms in patients with chronic asthma.
P L A I N L A N G U A G E S U M M A R Y
Ionisers for chronic asthma
Ion generators have been marketed for use in homes to remove dust and smoke particles in order to improve symptoms in people
with asthma. Although complex laboratory studies show that ion generators alter airways function, the few studies which have been
conducted in the homes of people with asthma, demonstrate no significant benefit in improving lung function or symptoms.
B A C K G R O U N D
Asthma is a chronic pulmonary disorder which affects an esti-
mated 3.4 million people in the UK (ONS 1996). A recent Na-
tional Asthma Campaign survey (Smith 2000) suggests that 42%
of those who have asthma face significant challenges in their daily
lives due to their condition. Two thirds of the asthma popula-
tion are said to be receiving inhaled steroids with many expressing
concerns about the long-term effects of their medication (Smith
2000). Although pharmacological interventions continue to im-
prove, the prevalence of asthma remains high (ONS 1996). Such
concerns highlight the need for further investigation into the ben-
efits of non-pharmacological treatment in order to compliment
pharmacological therapies.
Previous reports have shown that alteration of ions in the air may
have an effect on respiratory function (Wehner 1969). As a re-
sult, interest has grown in the physiological effects of positive and
negative air ions in people with asthma. With the development of
ion generators it has become possible to artificially manipulate the
ion content in air. Studies (Nogrady 1983; Lipin 1984; Warner
1993) have been carried out to test the efficacy of air ionisers in
order to reduce air-borne allergens and smoke particles, with a
view to alleviating asthma symptoms. Results of such studies are
often inconclusive and the effectiveness of air ionisers as a treat-
ment for asthma remains debatable. This systematic review of the
available evidence was conducted in order to summarise the results
of all identified randomised controlled trials comparing ionisers
to placebo.
O B J E C T I V E S
To determine whether air ionisers (positive or negative ion emit-
ters) are effective in relieving symptoms and improving respiratory
function in people with chronic asthma.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (parallel or crossover design studies).
Types of participants
We included studies assessing children and adults with chronic
asthma.
Types of interventions
Inhalation of positively or negatively ionised air, generated by an
ioniser in the home or laboratory setting. The comparative group
will have inhaled non-ionised air through a dummy ioniser.
Types of outcome measures
Primary outcomes
1. Respiratory physiological measures: Peak Expiratory Flow
(PEF) and Forced Expiratory Volume in one second (FEV1)
2. Asthma symptom scores
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Secondary outcomes
1. Health-related Quality of Life
2. Exacerbation
3. Provocation tests (e.g. exercise, histamine)
4. Bronchodilator usage
5. Inhaled corticosteroids usage
Search methods for identification of studies
Trials were identified using the Cochrane Airways Group Spe-
cialised Register of trials which is derived from systematic search-
ing of electronic databases including CENTRAL, MEDLINE,
EMBASE and CINAHL, and hand-searching of respiratory jour-
nals and meeting abstracts. All records in the Specialised Register
coded as ’asthma’ were searched using the following terms:
(ionis* or ioniz* or “electrostatic precipitator*”)
The Cochrane Central Register of Controlled Trials (CENTRAL)
was searched using the same terms. Additional searching was car-
ried out on the alternative medicine database AMED (1985 -
present) using the search:
#1 exp ASTHMA/
#2 asthma$ or wheez$
#3 1 or 2
#4 exp IONS/
#5 (ionis$ or ioniz$).tw.
#6 electrostatic$.tw.
#7 4 or 5 or 6
#8 3 and 7
Searches were current as of January 2010.
Data collection and analysis
Selection of studies
Two reviewers (KB and SLA) independently assessed titles and
abstracts of studies, identified by the database search, and selected
studies for inclusion in the review. We also independently assessed
the full text of all selected abstracts for suitability for inclusion in
the review.
Data extraction and management
We extracted data independently from the eligible studies. Dis-
agreement was resolved by consensus.
Assessment of risk of bias in included studies
We independently determined study quality using two methods:
(1) The Cochrane approach to allocation concealment using the
following grading system:
Grade A: Adequate concealment
Grade B: Uncertain
Grade C: Inadequate concealment
Grade D: allocation concealment not used
(2) The five point Jadad scale (Jadad 1996) according to the fol-
lowing criteria:
(a) Study described as randomised (yes: 1, no: 0)
(b) Method of randomisation described and appropriate (yes: 1,
no: -1)
(c) Study described as double blind (yes: 1, no: 0)
(d) Method of blinding described and appropriate (yes: 1, no: -1)
(e) There was a description of withdrawals and drop outs (yes: 1,
no: 0)
Data were extracted independently by both reviewers and authors
of trial reports were contacted for extra or missing information.
We resolved any disagreement between reviewers by discussion.
Data synthesis
Due to the crossover design employed in the studies, we could
not reliably pool data from the individual studies in RevMan,
and individual study data only is shown in the Forest plots. We
extracted first arm data for Nogrady 1983 and analysed this based
upon individual patient scores. We reported data for outcomes in
the crossover trials in the text of the review.
If parallel group data are available in future versions of this re-
view, we will report pooled analyses as weighted mean differences
(WMD) and standardised mean differences (SMD) depending
upon the availability of data measured on the same or different
metrics. If we can obtain suitable paired data for crossover studies,
we will combine this using inverse variance meta-analysis. Where
a more positive outcome is favourable, (e.g. PEF) data, we entered
this as positive values. In this case the titles of the horizontal axes
have been reversed so that effects that favour the treatment under
review move to the right. We have graphed continuous outcomes
for which lower scores imply improvement (e.g. symptom scores
and percentage reduction in FEV1 as a measure of bronchial reac-
tivity) according to standard Cochrane graphical convention such
that effects that favour the treatment under review move to the
left.
The following data were entered separately on the basis of:
(1) charge of ion emission, i.e. positive versus negative ions;
(2) duration of exposure to ionised air.
Subgroup analysis and investigation of heterogeneity
We performed a subgroup analysis on the basis of age group of
participants (adults versus children)
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R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Results of the search
We identified 22 abstracts from the original search , nine of which
were not trials. Thirteen full text articles were obtained. Two stud-
ies were excluded because they were not randomised (Kirkham
1984; Osterballe 1979) one was excluded because it was neither
randomised nor controlled (Jones 1976) and two studies were not
suitably controlled (Palti 1966; Zylberberg 1960) One study de-
termined the effect of ionisers on airborne particles but recorded
no patient outcomes (Wickman 1989) and one study reported
previously published data (Nogrady 1983). A total of six studies
were included in this review. An update search conducted in Jan-
uary 2010 did not identify any additional relevant studies.
Included studies
See Characteristics of included studies for details of individual
studies.
We included six studies in this review, all of which utilised a
crossover design. The review includes studies conducted between
1983 and 1994 two studies from Israel (Ben-Dov 1983; Lipin
1984) and four studies conducted in Australia (Nogrady 1983),
UK (Warner 1993) andDenmark (Daugbjerg 1988; Larsen 1994).
Two studies were published in Danish and were translated into
English (Daugbjerg 1988; Larsen 1994). The remaining studies
were all published in English.
Study design
All studies were randomised. One was single-blind (Daugbjerg
1988). The remaining studies were double-blind (Ben-Dov 1983;
Larsen 1994; Lipin 1984; Nogrady 1983; Warner 1993). No in-
formation on methods of randomisation were reported. Larsen
1994 provided details on the method of randomisation upon re-
quest.
Participants
Sixty eight children participated in four studies (Ben-Dov 1983
(n = 17); Lipin 1984 (n = 12); Daugbjerg 1988 (n = 19); Warner
1993 (n = 20)) with an age range of eight months to 20 years.
There were 40 adults who participated in two studies (Nogrady
1983 (n = 20); Larsen 1994 (n = 20)), with a mean age of 36 to
47 years.
Diagnosis and severity of asthma were not described in the studies.
Ben-Dov 1983 and Lipin 1984 recruited participants known to
have had asthma attacks provokedby exercise challenge.Daugbjerg
1988 did not report how a diagnosis of asthma was reached and no
baseline data on symptoms were reported. Larsen 1994 recruited
participants with an observed variation in peak flow of >20% or
reversibility of over 15% in FEV1 after inhalation of 0.2 mg of
salbutamol, were treated with </= 1000 mcg inhaled steroids per
day and required bronchodilators on a daily basis. Nogrady 1983
made a clinical assessment for asthma at the outset of the study,
including PEFR and allergen sensitivity. No other details of clin-
ical examination were reported. Warner 1993 recruited children
described as suffering from perennial asthma.
Interventions
Negatively ionised air was used in four home-based studies
(Daugbjerg 1988; Larsen 1994; Nogrady 1983;Warner 1993) and
one laboratory based study (Ben-Dov 1983). Positively ionised air
was used in one laboratory based study (Lipin 1984).
Nogrady 1983 exposed participants to 150,000 negative ions/ml
at night for 10 hours during the 8 week active treatment period.
Daugbjerg 1988 exposed participants to 220,000 negative ions
per cm3 or placebo for either eight and then four weeks or four
and then eight weeks treatment. In Larsen 1994 andWarner 1993
the ion count was not reported. In both studies participants were
exposed to an ioniser during the day in the living room and at
night in the bedroom for a treatment period of four weeks (Larsen
1994) and six weeks (Warner 1993).
Ben-Dov 1983 exposed participants to negatively charged ions
(0.5 to 1.0 x 106 ions per cm3 for approximately 45 minutes) and
conducted identical six minute exercise provocation tests (cycle
ergometry) where each challenge was undertaken twice (3 to 24
hours apart) with active and placebo ionisers. Participants were
also exposed to 4 to 5 x 105 negative ions per cm3 during his-
tamine provocation, with doubling concentrations of histamine to
a maximum of 10 mg/ml until a 20% drop in FEV1 was obtained
compared to baseline values. Each challenge was undertaken twice
(24 hours apart) with active and placebo ionisers.
Lipin 1984 exposed participants to positively charged ions (0.5
to 1.0 x 106 ions per cm3) and conducted identical six minute
exercise provocation tests (cycle ergometry) where each challenge
was undertaken twice (24 hours apart) with and without exposure
to the active ioniser.
Outcome measures
There was variation in the overall outcomes used across the six
studies.
The studies conducted under laboratory conditionsmeasured lung
function and did not assess symptoms or medication usage (Ben-
Dov 1983; Lipin 1984)
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Of the remaining studies, assessments were conducted of lung
function in three studies (Larsen 1994; Nogrady 1983 andWarner
1993); symptoms were assessed in three studies (Daugbjerg 1988;
Larsen 1994 andWarner 1993) and attempts to recordmedication
usage were made in two studies (Daugbjerg 1988; Warner 1993).
One study (Nogrady 1983) reported data with significant differ-
ences in baseline measurements (approximately 100 ml difference
in PEF) between the two comparison groups possibly due to the
gender distribution which is suggestive of unsuccessful randomi-
sation. Results were presented in the form of the two groups, ac-
cording to whether participants were exposed to the active ioniser
or the placebo ioniser first. Data from each group were analysed
separately and intra-group comparisons were made between the
active and placebo periods. A second publication of the trial con-
tributed no extra data to the review so is listed in ’excluded stud-
ies’.
Data from another study (Daugbjerg 1988) does not appear in the
table of comparisons as the data were not useable due to the use
of non-validated symptom scoring.
Risk of bias in included studies
Overall, the included papers were of strong study design. All
studies were conducted double-blind, except the Daugjberg study
(Daugbjerg 1988) which was single blind. The order of the treat-
ments within the crossover were described as randomised but ran-
domisation methods were not stated. However, none of the stud-
ies commented on the number of participants excluded from the
trials or reported a power calculation to determine sample size.
Withdrawals and drop-outs were adequately described.
The sample sizes of each of the six studies were small, ranging from
12 to 20 participants. The total number of participants contribut-
ing data from all six studies was 106.
A wash-out period between treatment arms of two weeks was re-
ported in only one study (Nogrady 1983). Although the duration
of exposure in the laboratory studies was short, it is unknown
whether a wash-out period of greater than 3 to 24 hours would be
required.
Inclusion/exclusion criteria were not formally specified. Inclusion
criteria was specified in two studies, with respect to a definition
of stable asthma (Larsen 1994), and a concentration of house
dust mite allergen Der p1 (Warner 1993) . The two laboratory
based studies reported a general statement of inclusion of subjects
as those being “known to have had asthmatic attacks provoked
by physical exertion”. Only one study specified exclusion criteria
relating to medication use (Larsen 1994).
There was total agreement between two independent assessments
of study quality using the Cochrane approach and the Jadad scale.
All five studies were graded B according to the Cochrane approach
to concealment of allocation as none described themethod of con-
cealment of allocation. This is not a major concern if the blinding
of participants and assessors was secure. No further details were
provided by the authors, about methods of concealment or ran-
domisation, which increased the allocated scores of the included
trials. All studies were given a Jadad score of 3.
Effects of interventions
EFFECTS OF NEGATIVE ION GENERATORS
Respiratory physiological measures
Peak Expiratory Flow
Morning PEF
Two studies with adult participants (Nogrady 1983; Larsen 1994)
did not report significant differences between the exposure peri-
ods.
One study conducted in children (Warner 1993) reported no sig-
nificant difference.
Evening PEF
No statistically significant differences were reported for evening
PEF (Nogrady 1983; Warner 1993; Larsen 1994). No values were
presented in the papers.
Forced Expiratory Volume in one second
Baseline FEV1
Only one study, which was a laboratory based study in children
(Ben-Dov 1983) measured FEV1 after 10 minutes inhalation of
control and negatively ionised air, but prior to exercise testing.
No significant differences were demonstrated in “Baseline” FEV1
between the treatment groups.
(ii) Percentage fall in FEV1 after exercise provocation
Ben-Dov 1983 demonstrated no significant difference in percent-
age reduction in FEV1 from baseline after exercise provocation
in the ionised air exposed group compared to those exposed to
control air.
(iii) Percentage fall in FEV1 after histamine provocation
Ben-Dov 1983 demonstrated no significant difference in percent-
age reduction in FEV1 from baseline after histamine provocation
in the ionised air exposed group compared to those exposed to
control air.
(iv) Absolute FEV1
Only one study, which was a home based study in adults (Larsen
1994) measured FEV1 after four weeks exposure to control and
negatively ionised air. This study determined there was no signif-
icant difference in absolute FEV1 (litres) between treatments.
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Asthma symptom scores
Three studies, one conducted in children (Warner 1993) and two
in adults (Nogrady 1983; Larsen 1994) recorded asthma symp-
toms. The Warner study utilised a different symptom scale while
the Nogrady and Larsen studies used the same. These measured
five dimensions of symptoms and reported a mean symptom score
only, not scores for the individual dimensions including the “To-
tal” dimension. Of these three studies, only the Larsen study re-
ported a “Total” dimension. Thus it was not possible to pool these
data in an analysis using a standardised mean difference and the
analyses are reported separately according to the use of Asthma
Symptom Scale “1” and Asthma Symptom Scale “2”.
Using the Asthma Symptom Score “1” (Warner 1993) there were
no significant differences between the treatments. After six weeks
exposure to both ionised air and control air, in the symptom di-
mensions of “nighttime wheeze”; “daytime wheeze”; “nighttime
cough” and “daytime activity”.
Using the Asthma Symptom Score “2” (Larsen 1994) there were
no significant differences between the treatments, after four weeks
exposure to both ionised and control air, in the symptom dimen-
sions scores of: “total”; “sleep disturbance”; “wheeze”; “activity
level”; “coughing” and “sputum production”.
Nogrady 1983 also used this scale, however, the authors reported
a mean of all five dimensions only. There was no significant dif-
ference between exposure periods in the mean symptom score.
Bronchodilator Use
Three studies recorded participants’ asthma medication use (in-
haled or oral bronchodilators, corticosteroids, sodium cromogly-
cate and other medications) (Nogrady 1983;Warner 1993; Larsen
1994). No study reported a significant difference in favour of
ionised air versus control.
EFFECTS OF POSITIVE ION GENERATORS
Only one study measured the effects of positive ions on lung
function. This study (Lipin 1984), conducted in children demon-
strated that positively ionised air was associated with bronchocon-
striction, measured by the maximum fall in FEV1 after exercise
from baseline (after 10 minutes exposure to ionised air but before
cycling) between treatment groups. The confidence interval of the
effect of positive ionisation on FEV1 after exercise includes no dif-
ference and also a clinically significant deterioration, but the sam-
ple size is too small to draw any firm conclusion. Baseline FEV1
was also demonstrated not to be significantly different between
treatment groups.
D I S C U S S I O N
The impact of weather and the resulting ionic charge of the air has
been thought to have an impact on biological systems (Sulman
1984) including the respiratory system (Palti 1966). Studies of
the effects of weather on morbidity have been conducted with
respect to the Foehn, a dry southerly wind of central Europe (
Posse 1975;GnecchiRuscone 1985) and although asthma patients
often report a worsening of symptoms with weather changes, early
studies indicate no relationship (Dantzler 1983; Wagner 1983).
Ion generators have been marketed for use to reverse negative ion
depletion and to remove dust and smoke particles by electrostatic
precipitation. There is a paucity of data in the literature generated
from randomised controlled trials of the effects of ion generators
for chronic asthma. Consequently this review has been limited by
the small numbers of studies eligible for inclusion in the review
and also the inconsistent use of outcome of measures. It is possible
that the studies lacked the statistical power to detect changes in
outcomes because of the small sample sizes of these studies, ranging
from 12 to 20.
The five studies of the effects of negative ion generators and the
one study of the effect of a positive ion generator included in this
review have failed generally to demonstrate any benefit of these
instruments for the treatment of chronic asthma in children and
adults. Relevant outcome measures such as PEF, FEV1 after exer-
cise and histamine provocation, symptom scores and asthmamed-
ication showed no significant improvement after extended periods
of exposure to charged ions compared to normal/control air. It is
important to note however that the Ben-Dov et al study (Ben-Dov
1983), a laboratory based study in children demonstrated that
during the active ionisation period, the FEV1 after exercise provo-
cation fell 8% less than that during the control air period. This
reduction in bronchial reactivity was statistically significant using
the Student’s paired t-test with a P value of less than 0.015. This
reflects the power inherent in a paired t-test, compared to the use
of a mean difference. The clinical relevance of this finding gener-
ated in a controlled laboratory setting with the concentration of
ions at the mouthpiece 100 times the natural concentration in the
air is unclear. Furthermore, a statistically significant reduction in
bronchial reactivity after histamine challenge did not occur. Inter-
estingly, four of nine participants demonstrated greater histamine
sensitivity during inhalation of negative ions compared to control
air.
The study by Lipin et al (Lipin 1984) also demonstrated a statis-
tically significant increase in bronchial reactivity after exercise in
participants during inhalation of positive ions (P = 0.04). In this
study, eight of twelve children experienced a greater reduction in
FEV1 when the active ioniser was used compared to the placebo
ioniser. Two showed no change and two showed a reduction in
reactivity. All other outcomes in this review were statistically con-
sistent with those reported by authors of the studies.
Asthma symptoms were not demonstrably improved as a con-
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sequence of active ionisation. The two studies, however, which
recorded or reported this outcome used two apparently un vali-
dated symptom scales; the Nogrady study (Nogrady 1983) which
utilised the same scale as the Larsen study (Larsen 1994) reported a
mean symptom score of the five dimensions rather than the “Total”
dimension score. The frequency of “nighttime cough” recorded in
the Warner study (Warner 1993) increased during the ionisation
period (exposure to negative ions for six weeks) to a level which
approached statistical significance [Wilcoxon signed rank sum test
P = 0.055]. If the use of room air ionisers is to be pursued then
this finding requires further investigation.
Asthma medication use was not demonstrated to be significantly
reduced during active ionisation compared to when the placebo
ioniser was in use. Beta-2 agonist use was an outcome measure
in only one of three studies which recorded medication use. The
amount of rescuemedication used is more likely to reflect a change
in condition as compared to other asthma medications.
One study (Larsen 1994) provoked some interesting correspon-
dence (Jonassen 1996) which suggests the need to carry out initial
trials on the efficiency of the ioniser before using it in a trial. The
ioniser is an instrumental component in the trial and could poten-
tially influence the trial outcome. Another point about the length
of time an ioniser should be turned on in order to ’clean’ the air
in a room is also worthy of consideration. Any trials implemented
to test an improvement of symptoms in asthma patients should
consider these points.
In conclusion, individual studies in a laboratory setting suggest
that positively ionised air may aggravate exercise induced asthma
and negatively ionised air may attenuate exercise induced asthma
during exposure to these charged ions at 100 fold the concentration
found naturally in the air. No other significant benefit or harm
in terms of lung function (baseline and absolute FEV1, PEF),
asthma symptoms or medication use were demonstrated and none
occurred in the home setting.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Based on the evidence currently available from randomised con-
trolled trials, a recommendation cannot be given for the use of
room air ionisers in the homes of patients with chronic asthma.
Implications for research
The strength of evidence from six randomised controlled trials
does not suggest that air ionisers are significantly beneficial for
patients with chronic asthma. There are no further data to provide
additional evidence to support their use and the absence of such
data in the medical literature since 1993 suggests a declining in-
terest. The review does suggest, however, that further trials would
need to incorporate issues on compliance, efficiency of the ioniser
and the environment in which the trial takes place.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ben-Dov 1983
Methods Crossover study
Randomisation method: unclear
Blinding: Double-Blind
Excluded: not described
Withdrawals: None stated
Baseline characteristics: comparable
Power calculation: not given
Jadad Score: 3
Participants Total = 17 children with asthma
(17 completing trial)
Gender-11M:6F. Age range 10-20 years, mean age 12.5 years
All patients had exercise-induced asthma
Inclusion/exclusion criteria-not stated
11 exercised challenged
10 histamine challenged
(4 participated in both)
No details of severity reported
Interventions Laboratory-based study:
Negatively ionised air (4x10/5-10x10/5 ions /cm3) versus
Control room or non-ionised air.
10 minutes pre-challenge (exercise and histamine) exposure, 6 minutes exercise test 3-24 hours apart. 3
minutes post-histamine challenge measurement.
Histamine provocative dose = PD20
Outcomes FEV1 measurement pre-challenge, during challenge and post-challenge
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Information not available
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Daugbjerg 1988
Methods Crossover study
Randomisation method: unclear
Blinding: single blind
Excluded: not described
Withdrawals: 3
No baseline statistics given
Power calculation: not given
Jadad score: 3
Participants Total = 19 children (16 completing trial)
Gender: 12m:7F
(9m:7F completing)
Average age 63 months
No baseline measurements taken
All patients had asthma or ’Wheezy Bronchitis’
Inclusion/exclusion criteria-not stated
No details of severity reported.
Interventions Home-based study: negatively ionised air versus control/non-ionised air
3 x 4-week periods
Outcomes In house developed four point symptom score; medication usage; parent reported school absence/days of
sickness
Notes Results not usable
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Information not available
Larsen 1994
Methods Crossover study
Randomisation method: Third party drew ’active’ or ’placebo’ labels out of an envelope (personal com-
munication from trialist).
Blinding: Double-blind
Excluded: not stated
Withdrawals: 1
Baseline characteristics: comparable
Power calculation: not given
Jadad score: 5
Participants Total = 20 adults (19 completing trial)
Gender: 9M:10F (one dropout), Age range 18-60 years, mean age 47
All patients had asthma
Inclusion criteria-stable asthma defined by oral steroid use
Variation in PEF of > 20% or > 15% FEV1 reversibility after 0.2mg salbutamol delivered by spacer
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Larsen 1994 (Continued)
Inhaled steroid use < 1000mcg/day ipratropium bromide/sodium cromoglycate
Interventions Home-based
Ionised air versus control/
non-ionised air 24hours per day, Positive or negative not stated
Ionised air for 4 weeks then control air for 4 weeks
Outcomes Morning/evening PEF. FEV1, FVC, VC, Symptom scores
Notes Jadad score: 5
Higher scoring due to extra information provided by author through personal communication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Sealed envelope; investigators unaware as to treat-
ment group assignment
Lipin 1984
Methods Crossover study
Randomisation method: unclear
Blinding: double-blind
Withdrawals: none stated
Baseline statistics: comparable
Power calculation: not given
Jadad score: 3
Participants Total = 12 (12 completing trial)
Gender: 7M:5F, Age range 9-15 years, mean age 12 years
All patients were asthmatic
Inclusion/exclusion criteria-not stated
No details of severity were reported.
Interventions Laboratory-based study: Positively ionised air versus control/non-ionised air
10 minutes exposure and exposure during 6 minute exercise test. Tests carried out 24 hours apart
Outcomes Bronchial reactivity-
measuring the effect on FEV1
Notes
Risk of bias
Item Authors’ judgement Description
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Lipin 1984 (Continued)
Allocation concealment? Unclear Information not available
Nogrady 1983
Methods Crossover study
Randomisation method: unclear
Blinding: double-blind
Excluded: not stated
Withdrawals: 1
Power calculation: not given
Jadad score: 3
Participants Original version of study had a total no. = 20 adult
(19 completing trial).
Gender: 10M:9F Mean age 36 years
Original study group of 20 separated into groups (a) and (b) because of gender distribution between
groups and baseline lung function higher probably due to gender distribution
All patients had asthma
Inclusion/exclusion criteria-not stated
Group (a) consists of 10 subjects: 8 males and 2 females, which started study on the active ioniser and
whose mean (SD) baseline characteristics were:
am PEF: 399(132)
pm PEF: 442(103)
symptom score: 1.8(1.85)
medication: 5.9(2.9)
See Nogrady (b)
Interventions Home-based
Negatively ionised air or control/
non-ionised air. 2 x 8 week treatment arms with 4 weeks washout. Total length of trial 6 months
Outcomes Morning PEF measurement; Sympton scores
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Information not available
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Warner 1993
Methods Crossover study
Randomisation method: unclear
Blinding: double-blind
Excluded: not stated
Withdrawals: not described
Baseline characteristics: comparable
Power calculation: not given
Jadad score: 3
Participants Total = 20 (20 completing the trial)
No gender ration given.
Age range 3-11 years, median age 9 years
All patients had asthma
Inclusion criteria-Der p1 concentration in the living room and child’s bedroom > 2mg/m3 air
No details of severity reported.
Interventions Home-based
Negatively Ionised air versus non-ionised air/ control air. 6 weeks ionised, 6 weeks non-ionised/control.
Air sampling performed at beginning, middle and end of each period
Outcomes Morning/evening PEF, nightitme wheeze, daytime wheeze, nighttime cough, daytime cough, daytime
activity, medication
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Information not available
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Jones 1976 Not randomised
No control group
Kirkham 1984 Not randomised
Mitchell 1980 No placebo treatment
Not blinded
Nogrady 1983b Secondary report of included study [Nogrady(a) and Nogrady(b)] No extra data extracted
Osterballe 1979 Not randomised
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(Continued)
Palti 1966 Groups not comparable. One group of 13 suffering from asthmatic bronchitis. One group of 6 with no
respiratory problems
Ponomarenko 2003 Study inadequately described to determine whether it was randomised or not
Wickman 1989 Randomised control trial measuring the ionisers effect on the reduction of airborne particles. Correspondence
with author revealed no patient data as none was originally recorded
Zylberberg 1960 No placebo group
Compared negative ionisation with positive ionisation
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D A T A A N D A N A L Y S E S
Comparison 1. Negative ionised air versus non-ionised air
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 FEV1 (Fall %) after exercise test 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Adults 0 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 Children 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Baseline FEV1(litres) (after
inhalation of negative ions
prior to exercise testing)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Adults 0 Mean Difference (IV, Fixed, 95% CI) Not estimable
2.2 Children 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
3 Morning Peak Expiratory Flow
(Litres/min)
3 Mean Difference (IV, Fixed, 95% CI) Totals not selected
3.1 Adults 2 Mean Difference (IV, Fixed, 95% CI) Not estimable
3.2 Children 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4 FEV1 (Litres/min) > 4 weeks 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Adults 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
4.2 Children 0 Mean Difference (IV, Fixed, 95% CI) Not estimable
5 Evening Peak Expiratory Flow
(Litres/min)
3 Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 Adults 2 Mean Difference (IV, Fixed, 95% CI) Not estimable
5.2 Children 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
6 FEV1 (Fall %) after histamine
challenge
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 Adults 0 Mean Difference (IV, Fixed, 95% CI) Not estimable
6.2 Children 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
7 Asthma Symptom Score 1 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 nighttime wheeze 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
7.2 daytime wheeze 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
7.3 nighttime cough 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
7.4 daytime activity 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
8 Asthma Symptom Score 2 2 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8.1 sleep disturbance 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
8.2 wheeze 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
8.3 activity level 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
8.4 coughing 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
8.5 sputum production 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
8.6 TOTAL 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
8.7 mean score of all five
dimensions
1 Mean Difference (IV, Fixed, 95% CI) Not estimable
9 Bronchodilator use 3 Std. Mean Difference (IV, Fixed, 95% CI) Totals not selected
9.1 Adults 2 Std. Mean Difference (IV, Fixed, 95% CI) Not estimable
9.2 Children 1 Std. Mean Difference (IV, Fixed, 95% CI) Not estimable
10 Morning PEFR (First arm
change score)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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Comparison 2. Positive ionised air versus non-ionised air
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 FEV1 (Fall %) after exercise test 1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Adults 0 Mean Difference (IV, Fixed, 95% CI) Not estimable
1.2 Children 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
2 Baseline FEV1(litres) (after
inhalation of positive ions prior
to exercise testing)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
2.1 Adults 0 Mean Difference (IV, Fixed, 95% CI) Not estimable
2.2 Children 1 Mean Difference (IV, Fixed, 95% CI) Not estimable
Analysis 1.1. Comparison 1 Negative ionised air versus non-ionised air, Outcome 1 FEV1 (Fall %) after
exercise test.
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 1 FEV1 (Fall %) after exercise test
Study or subgroup Ionised air Non-ionised air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
2 Children
Ben-Dov 1983 11 21 (9.9) 11 29 (16.6) -8.00 [ -19.42, 3.42 ]
-100 -50 0 50 100
Favours ionised air Favours control air
16Ionisers for chronic asthma (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.2. Comparison 1 Negative ionised air versus non-ionised air, Outcome 2 Baseline FEV1(litres)
(after inhalation of negative ions prior to exercise testing).
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 2 Baseline FEV1(litres) (after inhalation of negative ions prior to exercise testing)
Study or subgroup Ionised air Control air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
2 Children
Ben-Dov 1983 11 1.35 (0.26) 11 1.37 (0.23) -0.02 [ -0.23, 0.19 ]
-4 -2 0 2 4
Favours control air Favours ionised air
Analysis 1.3. Comparison 1 Negative ionised air versus non-ionised air, Outcome 3 Morning Peak
Expiratory Flow (Litres/min).
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 3 Morning Peak Expiratory Flow (Litres/min)
Study or subgroup Ionised air Non-ionised air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
Larsen 1994 19 354.9 (123.7) 9 357.8 (137.9) -2.90 [ -108.78, 102.98 ]
Nogrady 1983 10 403 (120) 10 416 (121) -13.00 [ -118.62, 92.62 ]
2 Children
Warner 1993 20 232.6 (87.5) 20 231.3 (96.5) 1.30 [ -55.79, 58.39 ]
-100 -50 0 50 100
Favours control air Favours ionised air
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Analysis 1.4. Comparison 1 Negative ionised air versus non-ionised air, Outcome 4 FEV1 (Litres/min) > 4
weeks.
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 4 FEV1 (Litres/min) > 4 weeks
Study or subgroup Ionised air Non-ionised air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
Larsen 1994 19 2.38 (1.1) 19 2.47 (0.95) -0.09 [ -0.74, 0.56 ]
2 Children
-4 -2 0 2 4
Favours control air Favours ionised air
Analysis 1.5. Comparison 1 Negative ionised air versus non-ionised air, Outcome 5 Evening Peak Expiratory
Flow (Litres/min).
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 5 Evening Peak Expiratory Flow (Litres/min)
Study or subgroup Ionised air Non-ionised air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
Larsen 1994 19 372 (125.2) 19 378.7 (139.7) -6.70 [ -91.05, 77.65 ]
Nogrady 1983 10 435 (103) 10 454 (115) -19.00 [ -114.69, 76.69 ]
2 Children
Warner 1993 14 239.2 (91.67) 14 232.8 (97.7) 6.40 [ -63.78, 76.58 ]
-100 -50 0 50 100
Favours control air Favours ionised air
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Analysis 1.6. Comparison 1 Negative ionised air versus non-ionised air, Outcome 6 FEV1 (Fall %) after
histamine challenge.
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 6 FEV1 (Fall %) after histamine challenge
Study or subgroup Ionised air Non-ionised air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
2 Children
Ben-Dov 1983 9 69 (15) 9 70 (18) -1.00 [ -16.31, 14.31 ]
-10 -5 0 5 10
Favours ionised air Favours control air
Analysis 1.7. Comparison 1 Negative ionised air versus non-ionised air, Outcome 7 Asthma Symptom Score
1.
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 7 Asthma Symptom Score 1
Study or subgroup Ionised air Control air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 nighttime wheeze
Warner 1993 14 0.19 (0.3) 14 0.2 (0.26) -0.01 [ -0.22, 0.20 ]
2 daytime wheeze
Warner 1993 14 0.2 (0.26) 14 0.18 (0.34) 0.02 [ -0.20, 0.24 ]
3 nighttime cough
Warner 1993 14 0.43 (0.71) 14 0.14 (0.15) 0.29 [ -0.09, 0.67 ]
4 daytime activity
Warner 1993 14 0.06 (0.11) 14 0.06 (0.15) 0.0 [ -0.10, 0.10 ]
-1 -0.5 0 0.5 1
Favours ionised air Favours control air
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Analysis 1.8. Comparison 1 Negative ionised air versus non-ionised air, Outcome 8 Asthma Symptom Score
2.
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 8 Asthma Symptom Score 2
Study or subgroup Ionised air Control air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 sleep disturbance
Larsen 1994 19 9.1 (12.1) 19 5.9 (9.7) 3.20 [ -3.77, 10.17 ]
2 wheeze
Larsen 1994 19 12.1 (17) 19 8.9 (15) 3.20 [ -6.99, 13.39 ]
3 activity level
Larsen 1994 19 13.7 (17.7) 19 11.6 (15.9) 2.10 [ -8.60, 12.80 ]
4 coughing
Larsen 1994 19 11.3 (15) 19 8.6 (10.5) 2.70 [ -5.53, 10.93 ]
5 sputum production
Larsen 1994 19 9.6 (12.8) 19 7.3 (10.6) 2.30 [ -5.17, 9.77 ]
6 TOTAL
Larsen 1994 19 55.8 (59.9) 19 42.3 (43.34) 13.50 [ -19.74, 46.74 ]
7 mean score of all five dimensions
Nogrady 1983 10 1.31 (1.49) 10 1.04 (1.42) 0.27 [ -1.01, 1.55 ]
-100 -50 0 50 100
Favours ionised air Favours control air
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Analysis 1.9. Comparison 1 Negative ionised air versus non-ionised air, Outcome 9 Bronchodilator use.
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 9 Bronchodilator use
Study or subgroup Ionised air Non-ionised air
Std.
Mean
Difference
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
Larsen 1994 19 56.37 (45.69) 19 55.16 (43.9) 0.03 [ -0.61, 0.66 ]
Nogrady 1983 10 5.96 (2.99) 10 5.16 (3.12) 0.25 [ -0.63, 1.13 ]
2 Children
Warner 1993 14 0.48 (0.67) 14 0.53 (0.94) -0.06 [ -0.80, 0.68 ]
-100 -50 0 50 100
Favours ionised air Favours control air
Analysis 1.10. Comparison 1 Negative ionised air versus non-ionised air, Outcome 10 Morning PEFR (First
arm change score).
Review: Ionisers for chronic asthma
Comparison: 1 Negative ionised air versus non-ionised air
Outcome: 10 Morning PEFR (First arm change score)
Study or subgroup Treatment Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Nogrady 1983 10 3.4 (23.8) 9 -0.78 (24.9) 4.18 [ -17.78, 26.14 ]
-10 -5 0 5 10
Favours control air Favours ionised air
21Ionisers for chronic asthma (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Positive ionised air versus non-ionised air, Outcome 1 FEV1 (Fall %) after
exercise test.
Review: Ionisers for chronic asthma
Comparison: 2 Positive ionised air versus non-ionised air
Outcome: 1 FEV1 (Fall %) after exercise test
Study or subgroup Ionised air Non-ionised air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
2 Children
Lipin 1984 12 35 (17.3) 12 25 (17.3) 10.00 [ -3.84, 23.84 ]
-100 -50 0 50 100
Favours ionised air Favours control air
Analysis 2.2. Comparison 2 Positive ionised air versus non-ionised air, Outcome 2 Baseline FEV1(litres)
(after inhalation of positive ions prior to exercise testing).
Review: Ionisers for chronic asthma
Comparison: 2 Positive ionised air versus non-ionised air
Outcome: 2 Baseline FEV1(litres) (after inhalation of positive ions prior to exercise testing)
Study or subgroup Ionised air Control air
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Adults
2 Children
Lipin 1984 12 1.64 (0.41) 12 1.66 (0.41) -0.02 [ -0.35, 0.31 ]
-1 -0.5 0 0.5 1
Favours control air Favours ionised air
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WH A T ’ S N E W
Last assessed as up-to-date: 18 January 2010.
Date Event Description
19 January 2010 New search has been performed Literature search re-run; no new studies.
H I S T O R Y
Protocol first published: Issue 4, 2000
Review first published: Issue 3, 2003
Date Event Description
1 August 2008 Amended Converted to new review format.
1 February 2003 New citation required and conclusions have changed Substantive amendment
C O N T R I B U T I O N S O F A U T H O R S
KB and SLA developed the protocol with suggested changes from CJC
KB carried out searches and KB and SLA reviewed abstracts for inclusion
KB and SLA extracted data with advice on data entry from CJC
SLA conducted the meta-analysis and reported results
KB wrote the abstract. SLA and KB developed the discussion and conclusion section with CJC.
D E C L A R A T I O N S O F I N T E R E S T
None known.
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S O U R C E S O F S U P P O R T
Internal sources
• None, UK.
External sources
• None, UK.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Air Ionization; Anions [therapeutic use]; Asthma [∗therapy];Cations [therapeutic use]; Ions [∗therapeutic use]; RandomizedControlled
Trials as Topic
MeSH check words
Adult; Child; Humans
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